* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Leukaemia Section t(1;9)(p34;q34) Atlas of Genetics and Cytogenetics
Promoter (genetics) wikipedia , lookup
Non-coding DNA wikipedia , lookup
Magnesium transporter wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Histone acetylation and deacetylation wikipedia , lookup
Protein (nutrient) wikipedia , lookup
RNA polymerase II holoenzyme wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Transcriptional regulation wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Protein moonlighting wikipedia , lookup
Non-coding RNA wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Western blot wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
Paracrine signalling wikipedia , lookup
Molecular evolution wikipedia , lookup
Signal transduction wikipedia , lookup
Protein adsorption wikipedia , lookup
Protein domain wikipedia , lookup
Epitranscriptome wikipedia , lookup
Silencer (genetics) wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Proteolysis wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Mini Review t(1;9)(p34;q34) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France (JLH) Published in Atlas Database: May 2011 Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0109p34q34ID2143.html DOI: 10.4267/2042/46057 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology association of HNRNPL and SFPQ drives the change in PTPRC (CD45) splicing (CD45 undergoes alternative splicing in response to T-cell activation). DNA damage: DNA double-strand breaks are repaired via nonhomologous DNA end joining and homologous recombination. The SFPQ/NONO heterodimer enhances DNA strand break rejoining. SFPQ has homologous recombination and non-homologous end joining activities. SFPQ is associated with the RAD51 protein complex. Role in transcriptional regulation: SFPQ and PTK6 (protein tyrosine kinase 6, also called BRK) play a role downstream of the EGF receptor (EGFR). SFPQ and NONO form complexes with the androgen receptor (AR) and modulate its transcriptional activity (Huret, 2011). Clinics and pathology Disease B cell progenitor acute lymphoid leukemia (B-ALL) Epidemiology Only one case to date, a 22-year-old male patient (Hidalgo-Curtis et al., 2008). Prognosis Complete remission was obtained, a relapse occured. The patient was in complete remission 6 years after diagnosis. Cytogenetics Cytogenetics morphological ABL1 The translocation was found solely in the main clone, and a subclone also showed a +21. Location 9q34 Protein ABL1, when localized in the nucleus, induces apoptosis after DNA damage. Cytoplasmic ABL1 has a possible function in adhesion signalling (Turhan, 2008). Genes involved and proteins SFPQ Location 1p34.3 Protein DNA- and RNA binding protein; pre-mRNA splicing factor; binds specifically to intronic polypyrimidine tracts. Role in transcription and RNA splicing: SFPQ, often called PSF, is a coactivator of Fox proteins, which bind the RNA element UGCAUG and regulate alternative pre-mRNA splicing. SFPQ and NONO are part of a large complex with all the snRNPs. SFPQ is phosphorylated by GSK3, which prevents SFPQ from binding PTPRC (CD45 antigen) pre-mRNA. The Atlas Genet Cytogenet Oncol Haematol. 2010; 14(10) Result of the chromosomal anomaly Hybrid gene Description Break in the 3' of SFPQ exon 10 and reunion with ABL1 intron 3; a further mRNA splicing gives rise to a chimeric SFPQ exons 1 to 9 (nucleotide 2072) fused to ABL1 exon 4 to end. 974 t(1;9)(p34;q34) Huret JL Fusion protein References Description 1609 amino acids fusion protein of 174 kDa; retains most of SFPQ, including the RNA recognition motifs and the coiled-coil domain (dimerization domain), fused to the SH2 domain of ABL1; the fusion protein also includes the SH1 domain (tyrosine kinase activity), the nuclear localization domain, and the actin binding domain of ABL1. Oncogenesis Constitutive tyrosine kinase activation is likely, through dimerization of the fusion protein. Huret JL.. SFPQ (splicing factor proline/glutamine-rich). Atlas Genet Cytogenet Oncol Haematol. January 1999. http://atlasgeneticsoncology.org/Genes/PSFID167.html Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts MW, Finkelstein JZ, Mould S, Oscier D, Cross NC, Grand FH.. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer. 2008 May;47(5):37985. Turhan AG.. ABL1 (v-abl Abelson murine leukemia viral oncogene homolog 1). Atlas Genet Cytogenet Oncol Haematol. August 2008. http://atlasgeneticsoncology.org/Genes/ABL.html This article should be referenced as such: Huret JL. t(1;9)(p34;q34). Atlas Genet Cytogenet Oncol Haematol. 2011; 15(11):974-975. Atlas Genet Cytogenet Oncol Haematol. 2010; 14(10) 975